Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses.
Interferon regulatory factor 3 (IRF3) is important for innate antiviral responses; accordingly, many viruses target and inactivate IRF3. The ability of the Herpes simplex virus type 1 (HSV-1) immediate early protein ICP0 to inhibit IRF3 is controversial and has not been studied solely in the context of a wild type HSV-1 infection. Discrepancies in the literature surround the mechanism by which ICP0 antagonizes the IRF3 pathway, the cellular localization of ICP0 inhibitory activity and the ability of ICP0 to interfere with interferon and interferon-stimulated gene induction. In this study, we set out to investigate the role of ICP0 localization and the requirement of the proteasome during the inhibition of IRF3 activation within the context of an HSV-1 infection. Collectively, the results presented herein demonstrate that incoming wild type HSV-1 activates IRF3 and that de novo produced ICP0 prevents sustained IRF3 activation following its translocation from the nucleus to the cytoplasm. While previous studies implicate the E3 ubiquitin ligase domain of ICP0 in mediating its biological functions, including the inhibition of IRF3, we show that cytoplasmic ICP0 does not require the proteasome for this activity. Instead, proteasome function is required to localize ICP0 to the cytoplasm where it mediates its inhibitory effect independent of E3 ubiquitin ligase activity. The importance of these findings is discussed within the context of an HSV-1 infection.
Paladino
Patrick
P
Department of Pathology and Molecular Medicine, Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Collins
Susan E
SE
Mossman
Karen L
KL
D021581:Active Transport, Cell Nucleus; D002478:Cells, Cultured; D003593:Cytoplasm; D006561:Herpes Simplex; D018259:Herpesvirus 1, Human / Q000276:immunology*; D006801:Humans; D017874:Immediate-Early Proteins / Q000032:analysis / Q000276:immunology; D007113:Immunity, Innate; D050838:Interferon Regulatory Factor-3 / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism; D046988:Proteasome Endopeptidase Complex; D014764:Viral Proteins / Q000032:analysis / Q000276:immunology*
C494232:IRF3 protein, human; D017874:Immediate-Early Proteins; D050838:Interferon Regulatory Factor-3; D014764:Viral Proteins; D046988:Proteasome Endopeptidase Complex
J Gen Virol. 1989 May;70 ( Pt 5):1185-202
2543774
J Leukoc Biol. 2008 May;83(5):1249-57
18252870
Mol Cell Biol. 1999 Apr;19(4):2465-74
10082512
J Virol. 2004 Aug;78(16):8411-20
15280450
J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):879-89
16960018
J Immunol. 2006 Dec 1;177(11):8008-16
17114474
J Virol. 1992 May;66(5):2904-15
1313909
J Immunol. 2007 Jul 15;179(2):1166-77
17617610
Nat Rev Immunol. 2006 Sep;6(9):644-58
16932750
J Interferon Cytokine Res. 2009 Sep;29(9):599-607
19694546
EMBO J. 1998 Feb 16;17(4):1087-95
9463386
J Virol. 2008 Feb;82(4):1701-13
18057247
Blood. 2009 Apr 2;113(14):3264-75
18952891
J Virol. 2004 Feb;78(4):1706-17
14747536
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8184-9
10393969
J Gen Virol. 2000 Sep;81(Pt 9):2215-2218
10950979
J Virol. 1997 Feb;71(2):1019-24
8995621
Genes Cells. 1996 Jun;1(6):569-79
9078386
J Biol Chem. 2001 Jan 5;276(1):355-63
11035028
Antimicrob Agents Chemother. 1977 May;11(5):919-22
195514
J Virol. 2001 Oct;75(19):8909-16
11533154
J Virol. 2004 Feb;78(4):1675-84
14747533
J Virol. 2000 Feb;74(4):2052-6
10644380
J Virol. 2008 Sep;82(17):8871-81
18579584
J Virol. 2009 May;83(9):4013-22
19211751
J Virol. 2006 Jan;80(1):218-25
16352546
J Virol. 2000 Nov;74(21):9994-10005
11024128
J Mol Biol. 1988 Jul 5;202(1):87-96
2845096
J Virol. 2001 Jan;75(2):750-8
11134288
J Virol. 2007 Aug;81(15):8091-100
17507487
EMBO J. 1994 Nov 1;13(21):5062-9
7957072
Bioessays. 2000 Aug;22(8):761-70
10918307
EMBO J. 1998 Dec 15;17(24):7161-9
9857173
Virology. 2000 Feb 15;267(2):209-19
10662616
J Virol. 2005 May;79(10):6419-31
15858025
J Virol. 2008 Nov;82(21):10647-56
18715910
J Virol. 2001 Sep;75(17):7904-12
11483735
J Virol. 1997 Oct;71(10):7328-36
9311810
Nucleic Acids Res. 1991 May 11;19(9):2499
2041787
J Gen Virol. 1994 Jun;75 ( Pt 6):1223-33
8207389
J Virol. 1993 Jul;67(7):3891-900
8389911
J Virol. 2009 May;83(10):4963-77
19264778
J Gen Virol. 1977 Nov;37(2):297-310
200709
Nucleic Acids Res. 1991 Nov 25;19(22):6155-61
1659686
J Virol. 2002 Jun;76(11):5532-9
11991981
Nat Immunol. 2007 Nov;8(11):1179-87
17952043
J Virol. 2002 Mar;76(5):2180-91
11836395
J Virol. 2006 Jan;80(1):226-35
16352547
Cell Cycle. 2005 Aug;4(8):1019-21
16082207
Immunity. 2006 Sep;25(3):349-60
16979567
J Virol. 2004 Mar;78(5):2169-78
14963113
J Virol. 2001 Apr;75(8):3832-40
11264372
J Gen Virol. 1986 Dec;67 ( Pt 12):2571-85
3025339
J Antimicrob Chemother. 1977 Mar;3 Suppl A:63-70
193822
Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(1):29-41
16914094
J Virol. 2005 Jan;79(2):1232-43
15613350
Immunity. 2000 Oct;13(4):539-48
11070172
J Virol. 2002 Feb;76(3):1077-88
11773384
J Virol. 1998 Aug;72(8):6581-91
9658103
Immunity. 2007 Sep;27(3):370-83
17892846
J Virol. 2009 May;83(10):4978-83
19264774
Trends Mol Med. 2009 Aug;15(8):359-68
19665430
Virology. 1997 Sep 1;235(2):406-13
9281521
J Gen Virol. 2009 Sep;90(Pt 9):2209-20
19515829
J Virol. 1989 Nov;63(11):4579-89
2552142
Virology. 2007 Apr 10;360(2):305-21
17126870
J Gen Virol. 1993 Dec;74 ( Pt 12):2679-90
8277273
J Virol. 1994 May;68(5):3267-82
8151788
Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):483-90
17706453
Mol Cell Biol. 1998 May;18(5):2986-96
9566918
J Virol. 2002 Jan;76(2):841-50
11752173
Biochemistry. 1976 Jan 27;15(2):426-30
55273
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6322-7
11972054